Objectives： To detect the serum proteomic patterns by using SELDI-TOF-MS （surface enhanced laser desorption/ ionization-time of flight-mass spectrometry） technology and CM10 ProteinChip in colorectal cancer （CRC）...Objectives： To detect the serum proteomic patterns by using SELDI-TOF-MS （surface enhanced laser desorption/ ionization-time of flight-mass spectrometry） technology and CM10 ProteinChip in colorectal cancer （CRC） patients, and to evaluate the significance of the proteomic patterns in the tumour staging of colorectal cancer. Methods： SELDI-TOF-MS and CM10 ProteinChip were used to detect the serum proteomic patterns of 76 patients with colorectal cancer, among them, 10 Stage Ⅰ, 19 Stage Ⅱ, 16 Stage Ⅲ and 31 Stage Ⅳ samples. Different stage models were developed and validated by support vector machines, disctiminant analysis and time-sequence analysis. Results： The Model Ⅰ formed by 6 protein peaks （m/z： 2759.58, 2964.66, 2048.01, 4795.90, 4139.77 and 37761.60） could be used to distinguish local CRC patients （Stage Ⅰ and Stage Ⅱ） from regional CRC patients （Stage Ⅲ） with an accuracy of 86.67% （39/45）. The Model Ⅱ formed by 3 protein peaks （m/z： 6885.30, 2058.32 and 8567,75） could be used to distinguish locoregional CRC patients （Stage Ⅰ, Stage Ⅱ and Stage Ⅲ） from systematic CRC patients （Stage IV） With an accuracy of 75.00% （57/76）. The Model Ⅲ could distinguish Stage Ⅰ from Stage Ⅱ with an accuracy of 86.21% （25/29）. The Model Ⅳ could distinguish Stage Ⅰ from Stage Ⅲ with accuracy of 84.62% （22/26）. The Model Ⅴ could distinguish Stage Ⅱ from Stage Ⅲ with accuracy of 85.71% （30/35）. The Model Ⅵ could distinguish Stage Ⅱ from Stage Ⅳ with accuracy of 80.00% （40/50）. The Model Ⅶ could distinguish Stage Ⅲ from Stage Ⅳ with accuracy of 78.72% （37/47）. Different stage groups could be distinguished by the two-dimensional scattered spots figure obviously. Conclusion： This method showed great success in preoperatively determining the colorectal cancer stage of patients.展开更多
基金Project (No. 30471987) supported by the National Natural ScienceFoundation of China
文摘Objectives： To detect the serum proteomic patterns by using SELDI-TOF-MS （surface enhanced laser desorption/ ionization-time of flight-mass spectrometry） technology and CM10 ProteinChip in colorectal cancer （CRC） patients, and to evaluate the significance of the proteomic patterns in the tumour staging of colorectal cancer. Methods： SELDI-TOF-MS and CM10 ProteinChip were used to detect the serum proteomic patterns of 76 patients with colorectal cancer, among them, 10 Stage Ⅰ, 19 Stage Ⅱ, 16 Stage Ⅲ and 31 Stage Ⅳ samples. Different stage models were developed and validated by support vector machines, disctiminant analysis and time-sequence analysis. Results： The Model Ⅰ formed by 6 protein peaks （m/z： 2759.58, 2964.66, 2048.01, 4795.90, 4139.77 and 37761.60） could be used to distinguish local CRC patients （Stage Ⅰ and Stage Ⅱ） from regional CRC patients （Stage Ⅲ） with an accuracy of 86.67% （39/45）. The Model Ⅱ formed by 3 protein peaks （m/z： 6885.30, 2058.32 and 8567,75） could be used to distinguish locoregional CRC patients （Stage Ⅰ, Stage Ⅱ and Stage Ⅲ） from systematic CRC patients （Stage IV） With an accuracy of 75.00% （57/76）. The Model Ⅲ could distinguish Stage Ⅰ from Stage Ⅱ with an accuracy of 86.21% （25/29）. The Model Ⅳ could distinguish Stage Ⅰ from Stage Ⅲ with accuracy of 84.62% （22/26）. The Model Ⅴ could distinguish Stage Ⅱ from Stage Ⅲ with accuracy of 85.71% （30/35）. The Model Ⅵ could distinguish Stage Ⅱ from Stage Ⅳ with accuracy of 80.00% （40/50）. The Model Ⅶ could distinguish Stage Ⅲ from Stage Ⅳ with accuracy of 78.72% （37/47）. Different stage groups could be distinguished by the two-dimensional scattered spots figure obviously. Conclusion： This method showed great success in preoperatively determining the colorectal cancer stage of patients.
